Multiplex Technology

Patented multiplex digital PCR technology platform enabling simultaneous analysis of 100+ genetic targets with absolute quantitation. Provides fast and reliable quantification for liquid biopsy applications across various genetic diseases.

Microfluidic biochip technology for multiplexed biomarker detection and analysis. Supports simultaneous testing of multiple analytes in diagnostic applications.

Multiplex real-time PCR platform enabling simultaneous detection of multiple target sequences. The technology provides high sensitivity and specificity for infectious disease diagnostics across various specimen types.

Advanced spectroscopic sensor combined with mathematical models for biomarker detection. Flexible platform compatible with various lateral flow and urine test formats.

Proprietary microfluidics technology platform designed for point-of-care testing and molecular diagnostics applications. Enables precise fluid handling and sample processing in miniaturized formats for rapid diagnostic analysis.

Point-of-care testing equipment and reagent platform for rapid immunochemical and biochemical diagnostics at the site of patient care.

Comprehensive micro-systems technology foundation enabling biosensor fabrication and microfluidic integration. Supports development of miniaturized bioanalytical devices for clinical applications.

A molecular diagnostics platform utilizing multiplex real-time PCR technology for simultaneous detection of multiple pathogens. Core technology supporting clinical and research diagnostic applications.

Genomtec’s platform technology enables fast and precise molecular analysis outside the laboratory environment without the need for qualified laboratory personnel. The solution utilises microfluidic technology and a proprietary lab-on-a-chip reaction card. Proprietary SNAAT® (Streamlined Nucleic Acid Amplification Technology) allows the detection of targeted DNA or RNA fragments in as little as 15 minutes, while maintaining effectiveness and performance comparable to currently used lab-based PCR methods. Genomtec serves the Clinical Diagnostics, Life Sciences, Veterinary, Food Safety, and Biosecurity markets. The company holds more than 5 patents and 3-5 trademarks.

Magnetic fluorescence encoded nanoreactor platform technology for multiplexed bioanalytical assays. Enables simultaneous detection of multiple analytes across diverse disease conditions and diagnostic applications. Accelerates diagnostic test development and expands testing capacity for clinical laboratories.

Multiplex diagnostic testing platforms enabling simultaneous detection of multiple biomarkers. Increases testing efficiency and reduces sample volume requirements.

Photonic solutions utilizing microsystem technology and nanopore diagnostics for rapid, precise disease detection and epigenetic biomarker analysis. These integrated sensor systems enable point-of-care diagnostics with reduced laboratory infrastructure requirements, supporting both diagnostic and therapeutic applications in modern clinical settings.